Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities
Net income (loss)	$ (171.8)	$ 1,224.8
Adjustments to reconcile net income (loss) to net cash flows from operating activities:
Depreciation and amortization	38.9	44.9
Equity-based compensation	78.3	107.8
Non-cash performance allocations and incentive fees	(239.6)	(242.0)
Non-cash principal investment (income) loss	646.3	(775.1)
Other non-cash amounts	(3.5)	8.0
Consolidated Funds related:
Realized/unrealized (gain) loss on investments of Consolidated Funds	219.2	(18.8)
Realized/unrealized (gain) loss from loans payable of Consolidated Funds	(180.3)	25.7
Purchases of investments by Consolidated Funds	(2,049.1)	(1,399.0)
Proceeds from sale and settlements of investments by Consolidated Funds	1,571.4	1,742.5
Non-cash interest income, net	(4.6)	(2.7)
Change in cash and cash equivalents held at Consolidated Funds	(258.2)	49.1
Change in other receivables held at Consolidated Funds	(20.0)	64.5
Change in other liabilities held at Consolidated Funds	149.4	(289.3)
Other non-cash amounts of Consolidated Funds	0.4	0.0
Purchases of investments	(214.1)	(216.5)
Payment of purchase price adjustment in Fortitude Re	(79.6)	0.0
Proceeds from the sale of investments	233.6	305.2
Changes in deferred taxes, net	4.7	21.6
Change in due from affiliates and other receivables	(8.3)	57.8
Change in deposits and other	(1.3)	(6.3)
Change in accounts payable, accrued expenses and other liabilities	(57.5)	(64.6)
Change in accrued compensation and benefits	73.0	99.3
Change in due to affiliates	(31.5)	0.3
Change in lease right-of-use assets and lease liabilities	(6.7)	(17.1)
Change in deferred revenue	200.3	203.9
Net cash (used in) provided by operating activities	(110.6)	924.0
Cash flows from investing activities
Purchases of fixed assets, net	(37.3)	(17.5)
Net cash used in investing activities	(37.3)	(17.5)
Cash flows from financing activities
Borrowings under credit facilities	287.1	42.3
Repayments under credit facilities	(300.6)	(17.0)
Issuance of 3.500% senior notes due 2029, net of financing costs	0.0	421.6
Repayment of term loan	0.0	(25.0)
Payments on debt obligations	(2.7)	(44.9)
Proceeds from debt obligations, net of financing costs	20.5	40.9
Net borrowings (payments) on loans payable of Consolidated Funds	594.6	(161.7)
Payments of contingent consideration	(0.3)	(0.2)
Dividends to common stockholders	(262.9)	(118.4)
Distributions to preferred unitholders	0.0	(17.7)
Distributions to non-controlling interest holders in Carlyle Holdings	0.0	(242.3)
Payment of deferred consideration for Carlyle Holdings units	(68.8)	0.0
Contributions from non-controlling interest holders	24.2	24.7
Distributions to non-controlling interest holders	(53.5)	(42.9)
Common shares repurchased	(26.4)	(34.5)
Change in due to/from affiliates financing activities	40.9	147.1
Net cash provided by (used in) financing activities	252.1	(28.0)
Effect of foreign exchange rate changes	6.6	(11.0)
Increase in cash, cash equivalents and restricted cash	110.8	867.5
Cash, cash equivalents and restricted cash, beginning of period	828.0	638.3
Cash, cash equivalents and restricted cash, end of period	938.8	1,505.8
Supplemental non-cash disclosures
Tax effects from the conversion to a Corporation recorded in equity	53.9	0.0
Net increase in partners’ capital and accumulated other comprehensive income related to reallocation of ownership interest in Carlyle Holdings	0.0	45.8
Non-cash distributions to non-controlling interest holders	0.0	(22.4)
Net asset impact of deconsolidation of Consolidated Funds	0.0	(24.3)
Tax effect from acquisition of Carlyle Holdings partnership units:
Deferred tax asset	0.0	6.1
Tax receivable agreement liability	0.0	5.1
Total partners’ capital	0.0	1.0
Reconciliation of cash, cash equivalents and restricted cash, end of period:
Total cash, cash equivalents and restricted cash, end of period	$ 938.8	$ 1,505.8